Analyst Ratings for Neogenomics (NEO) [Neutrals]
NEO Rating Summary
NEO Price Target Summary
- Highest: $24.00 (Needham)
- Lowest: $15.00 (BofA Securities)
- Average: $19.78
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.78 (+41%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
Avg. $ Target:
$19.78 (+41%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2023 | Raymond James | Andrew Cooper | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
12.84 (14.03) |
9.27% | Details |
| 3/29/2022 | BofA Securities » Updated 10/20/2023 |
Derik de Bruin | Downgrade | Neutral (Buy) |
15.00 (17.00) |
17.79 (14.03) |
-21.14% | Details |
 |
||||||||
|
||||||||
